Merck & Company, Inc. News Headlines

MRK 
$62.745
*  
0.255
0.41%
Get MRK Alerts
*Delayed - data as of Jan. 26, 2015 14:19 ET  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Despite Positive Phase 3 Results, Radius Health May Warrant A Short Sale
12/31/2014 5:00:00 AM - Seeking Alpha


Gilead Long-Term Prognosis Is Promising
12/30/2014 2:10:00 PM - Seeking Alpha


Esperion Therapeutics: ETC-1002 Is Appealing, But The Valuation Is Not
12/30/2014 7:22:00 AM - Seeking Alpha


DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
12/30/2014 7:05:00 AM - Seeking Alpha


Health Care SPDR Consolidating Gains as J&J, Merck Show Negative Trends
12/30/2014 6:10:00 AM - TheStreet


Why Dogs Of The Dow Doesn't Work Anymore
12/30/2014 4:46:00 AM - Seeking Alpha


Interesting March 2015 Stock Options for Merck
12/29/2014 12:21:19 PM - BNK Invest


Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog
12/29/2014 12:10:00 PM - Investopedia


Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog
12/29/2014 12:10:00 PM - Zacks.com


NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog
12/29/2014 12:00:00 PM - Investopedia


NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog
12/29/2014 12:00:00 PM - Zacks.com


The Unfortunate Concern That Nearly Half of All Cancer Patients Face
12/27/2014 1:51:03 PM - Motley Fool


The Real Source Of A Santa Claus Rally
12/26/2014 8:35:00 PM - Seeking Alpha


Noteworthy ETF Outflows: VTV, MRK, WMT, BMY
12/26/2014 11:21:38 AM - BNK Invest


Merck's Diabetes Pipeline Candidates Are Sure Bets; Only A Matter Of When
12/26/2014 10:58:00 AM - Seeking Alpha


Can You Retire In Your 50s?
12/26/2014 2:38:00 AM - Seeking Alpha


Interesting MRK Put And Call Options For February 2015
12/24/2014 3:05:38 PM - BNK Invest


This Cancer Drug War Is Just Getting Started
12/24/2014 12:41:35 PM - Motley Fool


Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog
12/23/2014 5:45:00 PM - Zacks.com


Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog
12/23/2014 4:30:00 PM - Zacks.com


Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical
12/23/2014 12:45:00 PM - Seeking Alpha


Dow Movers: MRK, DD
12/23/2014 11:56:18 AM - BNK Invest


Bristol-Myers Oncology Drug Opdivo Receives FDA Approval - Analyst Blog
12/23/2014 5:45:00 AM - Investopedia


Medivation Licenses CureTech's Cancer Drug Pidilizumab - Analyst Blog
12/23/2014 4:30:00 AM - Investopedia


Cubist's Antibiotic Zerbaxa Wins FDA Nod for cUTI and cIAI - Analyst Blog
12/22/2014 4:30:00 PM - Zacks.com